US3134769A - 1-methyl-diosgenins - Google Patents
1-methyl-diosgenins Download PDFInfo
- Publication number
- US3134769A US3134769A US130358A US13035861A US3134769A US 3134769 A US3134769 A US 3134769A US 130358 A US130358 A US 130358A US 13035861 A US13035861 A US 13035861A US 3134769 A US3134769 A US 3134769A
- Authority
- US
- United States
- Prior art keywords
- methyl
- acetate
- keto
- diosgenin
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002844 melting Methods 0.000 claims description 17
- 230000008018 melting Effects 0.000 claims description 17
- 239000000243 solution Substances 0.000 description 30
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 28
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
- 150000001875 compounds Chemical class 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000000203 mixture Substances 0.000 description 22
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 21
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 19
- QMQIQBOGXYYATH-IDABPMKMSA-N Ruscogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QMQIQBOGXYYATH-IDABPMKMSA-N 0.000 description 18
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000005984 hydrogenation reaction Methods 0.000 description 15
- 230000003647 oxidation Effects 0.000 description 15
- 238000007254 oxidation reaction Methods 0.000 description 15
- BSUPFYRQXCQGLJ-UHFFFAOYSA-N Ruscogenin Natural products CC1CCC2(OC1)OC3C(O)C4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C BSUPFYRQXCQGLJ-UHFFFAOYSA-N 0.000 description 14
- 239000007864 aqueous solution Substances 0.000 description 14
- QMQIQBOGXYYATH-UHFFFAOYSA-N epiruscogenin Natural products CC1C(C2(CCC3C4(C)C(O)CC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 QMQIQBOGXYYATH-UHFFFAOYSA-N 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 229940109990 ruscogenin Drugs 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 230000021736 acetylation Effects 0.000 description 12
- 238000006640 acetylation reaction Methods 0.000 description 12
- ALTRINCJVPIQNK-NHIXJPGBSA-N delta5-convallamarogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CCC(=C)CO1 ALTRINCJVPIQNK-NHIXJPGBSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- ALTRINCJVPIQNK-HWOQDVLDSA-N 3-epineoruscogenin Natural products C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@H]4CC=C5C[C@H](O)C[C@@H](O)[C@]5(C)[C@@H]4CC[C@]23C)O[C@]16CCC(=C)CO6 ALTRINCJVPIQNK-HWOQDVLDSA-N 0.000 description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- -1 progestationals Chemical class 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 235000011149 sulphuric acid Nutrition 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000007127 saponification reaction Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000013019 agitation Methods 0.000 description 6
- 230000001476 alcoholic effect Effects 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 239000007818 Grignard reagent Substances 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 150000004795 grignard reagents Chemical class 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 150000001242 acetic acid derivatives Chemical class 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 150000003431 steroids Chemical group 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 3
- 230000000397 acetylating effect Effects 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 150000003128 pregnanes Chemical class 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 230000017105 transposition Effects 0.000 description 3
- VZRAKVPDZIQRGT-WZBAXQLOSA-N (8r,9s,10s,13r,14s,17r)-17-ethenyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C=C)[C@@H]4[C@@H]3CCC21 VZRAKVPDZIQRGT-WZBAXQLOSA-N 0.000 description 2
- VVFNKRFSOQCQJP-DDDPLHQBSA-N (8s,9s,10r,13s,14s,17s)-17-acetyl-1,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1C[C@@H]2[C@@]3(C)C(C)CC(=O)C=C3CC[C@H]2[C@@H]2CC[C@H](C(C)=O)[C@]21C VVFNKRFSOQCQJP-DDDPLHQBSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- WQLVFSAGQJTQCK-CAKNJAFZSA-N Yamogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 WQLVFSAGQJTQCK-CAKNJAFZSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Chemical class O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- KPVWDKBJLIDKEP-UHFFFAOYSA-L dihydroxy(dioxo)chromium;sulfuric acid Chemical compound OS(O)(=O)=O.O[Cr](O)(=O)=O KPVWDKBJLIDKEP-UHFFFAOYSA-L 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QAPUWNJNUGPVPM-NTUXHYESSA-N (17z,23z)-3-butyl-4,6,8,10,12,14,16,27-octahydroxy-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one Chemical compound CCCCC1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)CC(O)\C(C)=C/C=CC=C\C=C/C=CC(O)C(C)OC1=O QAPUWNJNUGPVPM-NTUXHYESSA-N 0.000 description 1
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PQGMAKFMGGZKBA-SRJGTTDWSA-N 1-[(8r,9s,10s,13s,14s)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]ethanone Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC=C(C(=O)C)[C@@]1(C)CC2 PQGMAKFMGGZKBA-SRJGTTDWSA-N 0.000 description 1
- KVUXYQHEESDGIJ-UHFFFAOYSA-N 10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,16-diol Chemical compound C1CC2CC(O)CCC2(C)C2C1C1CC(O)CC1(C)CC2 KVUXYQHEESDGIJ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OMIHGPLIXGGMJB-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]hepta-1,3,5-triene Chemical compound C1=CC=C2OC2=C1 OMIHGPLIXGGMJB-UHFFFAOYSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 238000006027 Birch reduction reaction Methods 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 238000007181 Dienone-phenol rearrangement reaction Methods 0.000 description 1
- 240000006890 Erythroxylum coca Species 0.000 description 1
- 229930183217 Genin Natural products 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- 208000035175 Oligomenorrhea Diseases 0.000 description 1
- 206010030295 Oligomenorrhoea Diseases 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 240000000353 Ruscus aculeatus Species 0.000 description 1
- 235000003500 Ruscus aculeatus Nutrition 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- UGAPHEBNTGUMBB-UHFFFAOYSA-N acetic acid;ethyl acetate Chemical compound CC(O)=O.CCOC(C)=O UGAPHEBNTGUMBB-UHFFFAOYSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- QAPUWNJNUGPVPM-UHFFFAOYSA-N chainin Natural products CCCCC1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)CC(O)C(C)=CC=CC=CC=CC=CC(O)C(C)OC1=O QAPUWNJNUGPVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000008957 cocaer Nutrition 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002899 hydroxyprogesterone Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 229960004719 nandrolone Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000000624 ovulatory effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 150000003126 pregnane derivatives Chemical class 0.000 description 1
- 230000001072 progestational effect Effects 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 125000003198 secondary alcohol group Chemical group 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Definitions
- the present invention provides a method of introducing a methyl group'into the 1-position of steroids possessing a double bond in the 5-position.
- the presence of the A bond is fundamental, since it can easily be caused to migrate to the 4-position and the majority of physiologically active steroids, such as progestationals, androgens, and anti-infiammatories are A compounds.
- new l-methyl-steroids and l-methylene steroids which are the l-methyl genius of the following general Formulae 1, 2 and 3, the l-methyl-pregnane derivatives of the following general Formula 4 and the l-methylenegenins of the following general Formulae 5 and 6:
- the 1-methyl-A -dehydro-estr0gens (described in United States Patent No. 2,671,092) may be prepared by rearrangement of A -3-keto-dehydrosteroids by treating the latter with a catalyst capable of producing the dienonephenol rearrangement; l-methyl-19-nor-testosterone and its derivatives [Ringold et coll., I. Am. Chem. Soc., 78,
- R is derived from a cyclic or non-cyclic aliphatic carboxylic acid or from an aromatic carboxylic acid.
- R is derived from a cyclic aliphatic or aromatic acid, the group --CO- which is included may be attached directly to the nucleus or may occur in a side chain and R may represent, for example,
- the spiroketal chain in general Formulae 1 and has the configuration 20oz, 22,3, 25D, as in the case of diosgenin, and the spiroketal chainin general Formula 3 has the configuration 20a, 22 3, 25L, as in the case of yamogenin.
- the ethylenic spiroketal chain is the same as in neoruscogenin [1. Robert, R. Vaupre and G. Poiget, C. R. Acad. Sc. 250, 3187 (1960)].
- a double bond always exists in the 4,5- or 5,6-position and may exist in the 1,2-position.
- a double bond is always present in the 4,5- or 5,6-position and may exist in the 1,2-position and/ or the 16,17-position.
- Y CH wherein Y has the significance previously assigned to it and Z' represents a hydrogen atom or a hydroxy or acetoxy group
- Z' represents a hydrogen atom or a hydroxy or acetoxy group
- a method for the preparation of a l-methyl-l- 5 hydroxy-steroid which comprises subjecting a 1,3-dihydroxy-steroid to oxidation in the 1-position, and reacting the resultant l-keto-steroid with a metallic derivative of methane.
- l-methyl-l-hydroxy-genins such as l-methyl-l-hydroxy-diosgenin or l-methyl-l-hydroxy- A -dehydrodiosgenin
- a metallic derivative of methane also referred to herein as a Grignard reagent
- CH MgI, CH Mg Br or CH Li a metallic derivative of methane
- the 3-acetoxy-1-keto-genins are obtained by selective acetylation of 1,3-dihydroxy-genins followed by oxidation in the 1-position or by selective oxidation in the 1- osition of 1,3-dihydroxy-genins followed by acetylation in the 3-position (these are shown as routes (3), (4), (5) and (1), (6), (5), respectively, in the following flow sheet).
- the route (3), (4), (5) it is preferable to reduce the 20-keto group to a secondary alcohol group and then to effect a selective acetylation in the 3- and 20-positions of the 1,3,20-trio1 obtained before oxidising in the 1-position.
- a 1-methyl-1,3-dihydroxy-20-ketopregnane derivative is obtained by using the routes (1), (2) or (1), (6), (5), while a l-methyl-1,3,20-trihydroxy- 6O pregnane derivative is obtained by using the route (3), (4), (5). It is possible to convert the latter type of derivative to the corresponding ZO-keto derivative.
- ruscogenin and neoruscogenin which are steroidic sapogenins isolated from Ruscus aculeatus L. [H. Lapin, C. R. Acad. Sc. 244, 3065 (1957); Ch. Sannie and H. Lapin, Bull. Soc. Chim. 1237 (1957); :J. Robert, R. Vaupre and G. Poiget, C. R. Acad. Sc., 250, 3187 (1960)].
- the hydrogenation step is preceded by saponification of the 1-methylene-3-acetoxy compound.
- the same series of reactions can be carried out starting from l-methyl-l-hydroXy-steroids of the pregnane series to produce l-methyl-pregnane derivatives.
- Sheet 1 Sheet 2 Sheet 5 Sheet 3 Sheet 4 represents either in the case of products having a 200:, 22/3, 25D spiroketal chain, and these are represented by the letter "a" being placed after the Roman numeral allotted to each compound,
- the same products (Va) and (Vb) can be prepared by acetylation of (11a) or (11b), for example by means of acetic anhydride in pyridine to obtain the corresponding acetates (IVa) and (IVb), which are thereafter reacted with a Grignard reagent.
- These derivatives (Wu) and (Nb), can also be obtained from (Ia) or (lb), of which selective acetylation in the 3-position gives the corresponding 3- acetates (IIIa) and (IIIb).
- the latter two compounds, dissolved in an appropriate solvent such as acetone, are oxidised at a temperature between 15 C. and +20 C. with an aqueous solution of a mixture of sulphuric and chromic acids.
- Va l-methyl-l-hydroxy-diosgenin
- Vb 1 methyl-1hydroxy-A -dehydrodiosgenin
- VI 1-methyl-A -pregnadiene-1,3fl-diol-20- one-l-acetate
- VIII lmethyl-l6a,17a-epoxy-A -pregnadiene-3,ZO-dione
- the product (XI) is acylated in the l7-position in the presence of toluene-p-sulphonic acid to give triacyl compound (XII) which is selectively saponified in the 3- position, for example with KI-ICO to obtain (XIII) which, dissolved in an appropriate solvent such as acetone, is oxidised at a temperature between -15 and +20 C. with an aqueous solution of a mixture of chromic and sulphuric acids, to give (XIV).
- Alkali treatment of (XIV) causes the displacement of the double bond from position 5 to position 4, the elimination of the acetoxy group in position 1 with formation of a double bond in position 1 and, at the same time, the saponification of the acyloxy group in the l7-position, to yield l-mcthyl-lh-hydroxy-1,2-dehydroprogesterone (XV).
- the acid treatment of (XIV) eliminates the l-acetoxy group with formation of a double bond in the 1-position, and also causes migration of the double bond in the 5- position to the 4-position. There is thus obtained 1- methyl 17cc acyloxy-l,Z-dehydroprogesterone (XVI).
- the product (XVI) can also be obtained by esterification of the hydroxyl group in the Hut-position of (XV), for example by treating it with a derivative of an acid R"OH, such as an anhydride or a chloride, in the presence of tolueneep-sulphonic acid.
- the compound (XIX), dissolved in an appropriate solvent such as acetone, is oxidised at a temperature between -l5 and +20 C. with an aqueous solution of a mixture of chromic and sulphuric acids to obtain A pregnen-3B,20 ⁇ 5'-diol-l-one-3,20-diacetate (XX) which is treated with a Grignard reagent, such as CH MgI or CH MgBr, in a suitable solvent and subsequently decomposed, with an acid or a solution of NH Cl, to yield 1-methyl-A -pregnen-1,3,43,20fi-triol (XXI).
- a Grignard reagent such as CH MgI or CH MgBr
- Va l-methyl-l-hydroxy-diosgenin
- Vb l-methyl-lhydroxy-A -dehydrodiosgenin
- the residue obtained by evaporation of the washing ether of the first fraction is agitated for 1 hour with 460 ml. of boiling di-isopropyl ether.
- the suspension is filtered while hot and the insoluble matter is washed with ml. of di-isopropyl ether.
- Saponification with alcoholic potassium hydroxide of the residue of evaporation of the diisopropyl ether which has been employed to purify the second fraction permits of recovering 67 g. of ruscogenin, melting point 198- 202.
- Neoruscogenin-3-acetate first fraction: 57 g., melting point 240-245 Neoruscogenin-3-acetate, second fraction, recrystallised from isopropanol: 11.4 g., melting point 2 40-245.
- Saponification by means of alcoholic potassium hydroxide of the residue of evaporation of the mother liquors of the second fraction permits of recovering 75 g. of neoruscogenin, melting point 19220 0 (D) l-KETO-DIOSGENIN-3-ACETATE (IVa) FROM (Ha) (E) 1-KETO-DIOSGENIN-3-ACETATE (IVa) FROM (Illa) 34 g. of ruscogenin-3-acetate dissolved in 4590 ml. of acetone are treated with 20.4 ml. of the oxidising solution prepared in procedure A(ii) at 13-15 with agitation in a nitrogen atmosphere.
- Example 1 1-METHYL1-HYDROXY-DIOSGENIN (Va) FROM.
- (Ila) 16.96 grams of l-keto-diosgenin dissolved in 400 ml. of anhydrous benzene are added to a solution of methylmagnesium iodide in ether (prepared from 40 g. of Mg, 130 g. of CH I and 760 ml. of anhydrous ether). The suspension is warmed at 4547 for 7 days and then slowly poured into an aqueous solution of NH Cl in Water (360 g. of NH Cl in 1900 ml. of iced water). The organic layer is separated and the aqueous solution is extracted with ether again.
- Example 2 1-l ⁇ 1ETHYL-1-HYDROXY-DIOSGENIN (Va) FROM (IVa) 7
- CH MgI prepared from 2.9 g. of Mg and 17 g. of CH I
- anhydrous ether is slowly added with gentle boiling a solution of 9.5 g. of (IVa) in 500 ml. of tetrahydrofuran. This addition takes about 1 hour.
- Ether is distilled otf and, during the distillation, tetrahydrofuran is added until the internal temperature rises to 63. At this point the distillation is interrupted and the mixture is boiled for 15 hours.
- the suspension is treated with 400 m1.
- Example 3 l-ME'IHYL-l-HYDROXY-A -DEHYDRODIOSGENIN (Vb) FROM (IVE) Y
- methylmagnesium iodide prepared from 3.86 g. of magnesium and 24.85 g. of methyl iodide in 266 ml. of anhydrous ether
- IVb 1-keto-A -dehydrodiosgenin-3-acetate
- the mixture is refluxed for 3 hours, shaken for a further hours at room temperature and then treated with 500 ml. of a aqueous solution of ammonium chloride.
- Example 6 1-METHYLENE-DIOSGENIN-3-ACETATE (XXXa) FROM (XXIXa) 6 millilitres of thionyl chloride are poured drop-bydrop into a solution of 10 g. of (XXIXa) in 170 ml. of pyridine maintained at 0. The solution is then agitated for 15 minutes at 0 and then poured into 900 ml. of iced water. The precipitate is filtered, washed with Water, dried and recrystallised from ethanol and then from isopropanol. 4.37 g. of (XXXa) are obtained, M.P. 156.
- Example 7 l-METHYL-DIOSGENIN-3-ACETATE (XXXIa) FROM (XXXa) 2 grams of l-methylene-diosgenin-3-acetate (XXXa) are hydrogenated in 225 ml. of ethanol in the presence of 1.5 g. of 5% palladium on charcoal at room temperature and atmospheric pressure. After fixation of 1 mole equivalent of hydrogen, the hydrogenation is stopped. The catalyst is filtered and the alcoholic liquor distilled to dryness in vacuo.
- Example LMETHYLENE-DIO SGENIN (XXXVIIL) FROM (XXXII) 8.17 grams of 1 methylene diosgenin 3 acetate (XXXa), prepared as described in Example 6 are added to a solution of 8.17 g. of potassium hydroxide pellets in 817 cc. of methanol; the mixture is heated to reflux for one hour under nitrogen and with agitation. After cooling the solution 8.17 cc. of acetic acid are added thereto and the mixture is evaporated to dryness under vacuum; the crystalline residue is taken up in 250 cc. of water, the solution filtered and the residue Washed with water and then dried over night under vacuum in the presence of concentrated sulphuric acid.
- Example 11 l-METHYLENE-M -DEHYDRODIOSGENIN (XXXVIb) FROM (XXXb) Following the procedure described in Example 10, but starting with 13.3 g. of 1-rnethylene-A -dehydrodiosgenin-3-acetate (XXXb) (M.P. 145-155) prepared as described in Example 8, there is obtained 5.73 g. of lmethylene-A -dehydrodiosgenin, M.P. l7l173.
- Example 12 l-METHYL-DIOSGENIN (XXXVIIa) FROM (XXXVIa) 1.33 grams of l-methylene-diosgenin (XXXVIa) dissolved in 66 cc. of ethanol are hydrogenated in the presence of 2.66 g. of 3% palladium on charcoal under atmospheric pressure and at room temperature. The hydrogenation is stopped after the absorption of 1.4 mole equivalents of hydrogen; the catalyst is then filtered off and the ethanolic solution evaporated to dryness under vacuum.
- Example 13 l-lVLER'llI-IYLYAMO'GENIN (XXXVIIc) FROM (XXXVIb) 2 grams of 1 methylene A dehydrodiosgenin (XXXVIb) dissolved in 100 cc. of ethyl acetate are hydrogenated in the presence of 1.6 g. of 10% palladium on barium sulphate under atmospheric pressure and at room temperature. The hydrogenation is stopped after the absorption of 2.3 mole equivalents of hydrogen; the catalyst is then filtered off and the filtrate evaporated to dryness under vacuum.
- the crude product is purified by two crystallisations from ethanol and there is obtained 0.32 got l-methylyamogenin, M.P. 177178.
- a process for the preparation of a compound selected from the class consisting of l-methyl-l-hydroxydiosgenin and l-methyl-l-hydroxy A dehydrodiosgenin which comprises acetylating in the 3-position a compound selected from the class consisting of ruscogenin and neoruscogenin with acetic anhydride, oxidising the acetyl derivative obtained with an agent selected from the class consisting of a sulphuric acid-chromic acid mixture and a pyridine-chromic anhydride complex, whereby the l-hydroxy group is converted to a l-oxo group, reacting the keto derivative obtained with a methyl magnesium halide and hydrolysing the resultant magnesium complex.
- a process for the preparation of a compound selected from the class consisting of l-methylene-diosgenin and 1-methy1ene-A -dehydrodiosgenin which comprises acetylating in the 3-position a compound selected from the class consisting of 1-methyl-l-hydroxy-diosgenin and l-methyl-l-hydroxy A dehydrodiosgenin with acetic anhydride, reacting the acetyl derivative thus obtained with thionyl chloride and de-acetylating the resultant product by reacting it with an alkali metal hydroxide.
- a process for the preparation of a compound selected from the class consisting of l-methyl-diosgenin and l-methyl-yamogenin which comprises hydrogenating a compound selected from the class consisting of l-methylene-diosgenin and l-methylene-A -dehydrodiosgenin with hydrogen in the presence of palladium.
- a process for the preparation of a compound selected from the class consisting of l-methyl-diosgenin-3- acetate and l-methyl-yamogenin-S-acetate which comprises hydrogenating a compound selected from the class consisting of 1-methylene-diosgenin-3-acetate and 1-metl1- ylene A2597) dehydrodiosgenin 3 acetate in an ethyl acetate-acetic acid medium and in the presence of a reagent selected from the class consisting of palladium and Adams platinum.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
May 26, 1964 B. CAMERINO ETAL l-METHYL-DIOSGENINS Filed Aug. 9, 1961 i Aco- Degradation AcO Hydrogenation Pd /C acetyiation AcQ- 11X Oxidation J Select ive CHOAc Aco- Grlgnard 3 CHOH 5 Sheets-Sheet 1 Acetylah'on H0- IaJb cocH AcO CH3 HO- YI Hydrogenatlon Pd/ C coca May 26, 1964 B. CAMERINO ETAL 3, 34,7 9
l-METHYL-DIOSGENINS Filed Aug. 9, 1961 5 Sheets-Sheet 2 HO- Ia.Ib
' Selective seleclilve acetylation oxidation Oxudahon Ce ylatlon Grignard AcO- Na, K b
l Grignard HO CH3 :XXXa HQ- m1 XXX 1: Oxidation y Acetylitiqn Hydrogenation cocHa sapom- Pa/C Ficakion COCH CH3 J AcO 3 AcO- AcO- XXXII:
Inventors fi'runa (Layer/v70 [P045607 Sal 4 4 V May 26, a, CR-MERiNO ETAL J Ill-METI'HMEHDEOSGENINS Filedi Aug, 9, 1961;. 5 Sheets-sheaf. 3
Attbrney;
United States Patent 3,134,769 l-METHYL-DIOSGENINS Bruno Camerino and Roberto Sciaky, both of Via Turati 18, Milan, Italy, and Jean Robert, 28 Ave. Pasteur, Gentilly, Seine, France Filed Aug. 9, 1961, Ser. No. 130,358 Claims priority, application Great Britain Oct. 28, 1959 11 Claims. (Cl. 260-43955) Patented May 26,- 1964 2477 (1956)] and 1-methyl-l9-nor progesterone and its derivatives [Djerassi et coll., J. Am. Chem. Soc., 78, 2479 (1956)] may be obtained by Birchs reduction of the corresponding l-methyl A -3-alkoxy-estratrienes; and 1- methyl-A -3-keto-dehydrosteroids, may be prepared by the action of diazomethane on A -3-keto-dehydrosteroids, followed by pyrolysis of the adduct [as described in German Patent Auslegeschrift No. 1,023,764].
The present invention provides a method of introducing a methyl group'into the 1-position of steroids possessing a double bond in the 5-position. The presence of the A bond is fundamental, since it can easily be caused to migrate to the 4-position and the majority of physiologically active steroids, such as progestationals, androgens, and anti-infiammatories are A compounds.
According to a first feature of the invention, there are provided new l-methyl-steroids and l-methylene steroids which are the l-methyl genius of the following general Formulae 1, 2 and 3, the l-methyl-pregnane derivatives of the following general Formula 4 and the l-methylenegenins of the following general Formulae 5 and 6:
group from the 10-to the 1-position; or they possess no wherein the various symbols used have the following double bond in the 4- or 5-position. For instance, the 1-methyl-A -dehydro-estr0gens (described in United States Patent No. 2,671,092) may be prepared by rearrangement of A -3-keto-dehydrosteroids by treating the latter with a catalyst capable of producing the dienonephenol rearrangement; l-methyl-19-nor-testosterone and its derivatives [Ringold et coll., I. Am. Chem. Soc., 78,
meanings:
Y: -H or OH or OCOCH or A (It will be noted that there is an additional hydrogen atom present in the l6-position, which has not been mentioned in the aforesaid values of Z.)
R: or (-H)OH or (H)OCOCH R: an acyl group containing up to 9 carbon atoms,
derived from a cyclic or non-cyclic aliphatic carboxylic acid or from an aromatic carboxylic acid. (If R is derived from a cyclic aliphatic or aromatic acid, the group --CO- which is included may be attached directly to the nucleus or may occur in a side chain and R may represent, for example,
Utilising the nomenclature of M. E. Wall and S. Serota [1. Am. Chem. Soc. 79', 6481 (1957)], the spiroketal chain in general Formulae 1 and has the configuration 20oz, 22,3, 25D, as in the case of diosgenin, and the spiroketal chainin general Formula 3 has the configuration 20a, 22 3, 25L, as in the case of yamogenin. In general Formulae 2 and 6 the ethylenic spiroketal chain is the same as in neoruscogenin [1. Robert, R. Vaupre and G. Poiget, C. R. Acad. Sc. 250, 3187 (1960)]. In the general Formulae 1, 2 and 3 a double bond always exists in the 4,5- or 5,6-position and may exist in the 1,2-position. In general Formula 4 a double bond is always present in the 4,5- or 5,6-position and may exist in the 1,2-position and/ or the 16,17-position.
selective Y CH wherein Y has the significance previously assigned to it and Z' represents a hydrogen atom or a hydroxy or acetoxy group, are physiologically active compounds which exhibit progestative properties and may be employed in the treatment of the following conditions: primary amenorrhea, functional dysrnenorrhea, hypo-oligo-menorrhea, sterility, menorrhagia, habitual abortion, threatened abortion and ovulatory disorders. This progestative activity is particularly pronounced in the case of 1-methyl-17aacetoxy-progesterone.
According to a further feature of the invention there is provided a method for the preparation of a l-methyl-l- 5 hydroxy-steroid which comprises subjecting a 1,3-dihydroxy-steroid to oxidation in the 1-position, and reacting the resultant l-keto-steroid with a metallic derivative of methane.
In a specific application of the foregoing general method the formation of l-methyl-l-hydroxy-genins, such as l-methyl-l-hydroxy-diosgenin or l-methyl-l-hydroxy- A -dehydrodiosgenin, is effected by the action of a metallic derivative of methane (also referred to herein as a Grignard reagent), such as CH MgI, CH Mg Br or CH Li, in an appropriate solvent, either:
(a) On l-keto-genins having a free hydroxyl group in the 3-position, such as l-keto-diosgenin or 1-keto- A -dehydrodiosgenin, which are prepared by selective oxidation in the 1-position of 1,3-dihydroxy-genins, such as ruscogenin and neoruscogenin (this is shown as route (1), (2) in the flow-sheet set out below) or (b) On 'l-keto-genins having an acetoxy group in the 3-position. The 3-acetoxy-1-keto-genins are obtained by selective acetylation of 1,3-dihydroxy-genins followed by oxidation in the 1-position or by selective oxidation in the 1- osition of 1,3-dihydroxy-genins followed by acetylation in the 3-position (these are shown as routes (3), (4), (5) and (1), (6), (5), respectively, in the following flow sheet).
(3H 0 H O C H; (1) ll selective Grignard A T A T A 13 on a 1011 reagen H 0 H O (6) lacetylation OH (I? oxidation Grignard A B A t rcagen R 0 Ru=acetyl group The steroids of the pregnane series can be obtained by similar methods. However, in the case of 20 keto-compounds, before proceeding with either of the above routes (1), (2) or (1), (6), (5) it is necessary to block the ZO-keto group, for example by forming a cyclic acetal, so that it does not react with the Grignard reagent.
Further, if the route (3), (4), (5) is used, it is preferable to reduce the 20-keto group to a secondary alcohol group and then to effect a selective acetylation in the 3- and 20-positions of the 1,3,20-trio1 obtained before oxidising in the 1-position. It is to be noted that, in the treatment by the above methods of compounds of the pregnane series, a 1-methyl-1,3-dihydroxy-20-ketopregnane derivative is obtained by using the routes (1), (2) or (1), (6), (5), while a l-methyl-1,3,20-trihydroxy- 6O pregnane derivative is obtained by using the route (3), (4), (5). It is possible to convert the latter type of derivative to the corresponding ZO-keto derivative.
As starting materials in carrying out the aforesaid process there may be employed ruscogenin and neoruscogenin which are steroidic sapogenins isolated from Ruscus aculeatus L. [H. Lapin, C. R. Acad. Sc. 244, 3065 (1957); Ch. Sannie and H. Lapin, Bull. Soc. Chim. 1237 (1957); :J. Robert, R. Vaupre and G. Poiget, C. R. Acad. Sc., 250, 3187 (1960)].
According to a further feature of the invention there is provided a method for the preparation of a l-methylsteroid free from a hydroxyl group in the 1-position which comprises acetylating in the 3-position a l-methyl- 7 1,3-dihydroxy-steroid, dehydrating in the 1-position the I bl/ acetylation A B A R Ru 0 dehydration hydrogenation (R.,=aeetyl group) In an alternative route, for the preparation of the corresponding 3-hydroxy compound, the hydrogenation step is preceded by saponification of the 1-methylene-3-acetoxy compound. The same series of reactions can be carried out starting from l-methyl-l-hydroXy-steroids of the pregnane series to produce l-methyl-pregnane derivatives.
According to a further feature of the invention there is provided a modification of the method set forth above for the preparation of a ll-HlfithYl-SIIBI'Oid free from a hydroxyl group in the 1-position wherein, for the preparation of 1-rnethyl-A -3-keto-steroids, the said l-methyl- 1,3-dihydroxy-steroid is oxidised in the 3-position and the resultant 3-keto compound is dehydrated.
It will be observed that in the above modification, Where the hydroxyl group in the El-position is oxidised, the dehydration step gives, not the l-methylene derivative, but the l-methyl-A derivative. And, further, since the dehydration is effected in a strongly acid or strongly alkaline medium, a transposition of the double bond from the 5-position to the 4-position occurs, which permits of directly isolating either the 1-methyl-A -3-keto-genins or the 1-methyl-A -B-keto-pregnane derivatives. As an alternative procedure it is possible to isomerise the said 3-keto compound, by treatment with an acid or alkali, into the corresponding A derivative prior to the dehydration step. These procedures are diagrammatically represented as follows:
According to a further feature of the invention there is provided a second modification of the method set forth above for the preparation of a l-methyl-steroid free from a hydroxyl group in the 1-position wherein, for the preparation of 1-methyl-A -3-keto-steroids, a 1- methyl-l-acetoxy-3-hydroxy-steroid is oxidised in the 3- position and the 3-keto compound thus obtained is treated with an alkali or acid whereby the elements of an acetic acid molecule are eliminated forming a double bond in the 1,2-position.
The series of transformations in the said second modification set forth above is accompanied by a transposition of the double bond in the A -position to the A position and can be diagrammatically represented as follows:
RIO I a RuO\(I3H3 C a Oxidation OH- A A B A B B0 o- 0 (R,,=acety1 group) It will be observed that when the 3-keto compound is treated with acid, the product, depending upon the operating conditions, is either a 1-methyl-A -3-keto-steroid or a 1-methyl-1-acetoxy-A -3-keto-steroid. The latter type of compound can be treated with acid or alkali to produce a A double bond.
' The various processes hereinbefore set forth are illustrated schematically in the accompanying drawings. The five sheets of drawings placed together in the following relative positions:
in the case of products having the ethylenic spiroketal chain of neuoruscogenin, and these are represented by C .0 I I in the case of products having a 20a,22B,25L spiroketal chain, and these are represented by the letter being placed after the Roman numeral allotted to each compound. In the formulae of the drawing, the group R" has the meaning hereinbefore given, and Ac represents the acetyl group.
Referring now to the accompanying drawing, selective oxidation of ruscogenin (Ia) or of neoruscogenin (Ib) to l-keto-diosgenin (Ila) or 1-keto-A -dehydrodiosgenin (IIb) can be carried out by the oxidation with pyridine CrO complex of (In) or (111), dissolved in pyridine, for about 12 to 24 hours at room temperature and with agitation. It is also possible to efiect the oxidation of (la) or (Ib), dissolved in an appropriate solvent such as acetone, with an aqueous solution of a mixture of chromic and sulphuric acids and operating at a temperature between and C. By reaction of l-keto-diosgenin (Ila) or l-keto-A dehydrodiosgenin (1112) with a Grignard reagent such as methylmagnesium bromide or iodide, in a solvent such as benzene, ether or tetrahydrofuran, or binary mixtures of these solvents, followed by decompostion with acids or aqueous solution of ammonium chloride, there is obtained 1 methyl 1 hydroxy diosgenin (Va) or 1 methyl-lhydroxy-A -dehydrodiosgenin (Vb). The same products (Va) and (Vb) can be prepared by acetylation of (11a) or (11b), for example by means of acetic anhydride in pyridine to obtain the corresponding acetates (IVa) and (IVb), which are thereafter reacted with a Grignard reagent. These derivatives (Wu) and (Nb), can also be obtained from (Ia) or (lb), of which selective acetylation in the 3-position gives the corresponding 3- acetates (IIIa) and (IIIb). The latter two compounds, dissolved in an appropriate solvent such as acetone, are oxidised at a temperature between 15 C. and +20 C. with an aqueous solution of a mixture of sulphuric and chromic acids.
Be degradation of l-methyl-l-hydroxy-diosgenin (Va) or of 1 methyl-1hydroxy-A -dehydrodiosgenin (Vb) there is obtained 1-methyl-A -pregnadiene-1,3fl-diol-20- one-l-acetate (VI), which can also be obtained by degradation of the products (XXIXa) and (XXlXb), of which the preparation will hereinafter be described.
The compound (VI), treated with hydrogen peroxide and alkali in methanolic solution, yields the 16a,17otepoxy derivative (VII), which by acetylation with pyridine and acetic anhydride may be transformed into the 1,3-diacetate (IX). This product (IX) can be converted back to compound (VII) by saponification. lmethyl-l6a,17a-epoxy-A -pregnadiene-3,ZO-dione (VIII) is synthesised from the 1,3-dihydroxy-l-acetate derivative (VII) which is oxidised, in an appropriate solvent such as acetone, with an aqueous solution of a mixture of chromic and sulphuric acids at '15 to +20 C. and treated with alcoholic alkali in order to obtain the A double bond.
1 methyl-l6a,l7zx-epoxy-A -pregnen-l,3fi-diol-20-onediacetate (IX) reacts with hydrobromic acid to yield the bromohydrin (X), in which the bromine is replaced by hydrogen by hydrogenation of (X), in the presence of palladium on charcoal and in the presence of an 8 alkaline reagent, such as triethylamine, ammonium acetate or calcium carbonate, to product (XI).
The product (XI) is acylated in the l7-position in the presence of toluene-p-sulphonic acid to give triacyl compound (XII) which is selectively saponified in the 3- position, for example with KI-ICO to obtain (XIII) which, dissolved in an appropriate solvent such as acetone, is oxidised at a temperature between -15 and +20 C. with an aqueous solution of a mixture of chromic and sulphuric acids, to give (XIV). Alkali treatment of (XIV) causes the displacement of the double bond from position 5 to position 4, the elimination of the acetoxy group in position 1 with formation of a double bond in position 1 and, at the same time, the saponification of the acyloxy group in the l7-position, to yield l-mcthyl-lh-hydroxy-1,2-dehydroprogesterone (XV).
The acid treatment of (XIV) eliminates the l-acetoxy group with formation of a double bond in the 1-position, and also causes migration of the double bond in the 5- position to the 4-position. There is thus obtained 1- methyl 17cc acyloxy-l,Z-dehydroprogesterone (XVI). The product (XVI) can also be obtained by esterification of the hydroxyl group in the Hut-position of (XV), for example by treating it with a derivative of an acid R"OH, such as an anhydride or a chloride, in the presence of tolueneep-sulphonic acid.
' Selective acetylation, with acetic anhydride and acetic acid under suitable conditions, is effected on A -prcgnen- 113,3/3,20{3-triol (XVIII), prepared by reduction of A pregnen 1,8,3/3 diol-20-one-l,3 diacetate (XVII) with LiAlH in a suitable solvent such as tetrahydrofuran or ether, to obtain the 3,20-diacetate (XIX). The product (XVII) [which is prepared from ruscogenin (la) or from neoruscogenin (Ib) by acetylation of the hydroxyl groups situated in 1- and 3-positions, degradation of the diacetate and hydrogenation with palladium on charcoal] is known [H. Lapin Bull. Soc. Chim. 1501 (1957)].
The compound (XIX), dissolved in an appropriate solvent such as acetone, is oxidised at a temperature between -l5 and +20 C. with an aqueous solution of a mixture of chromic and sulphuric acids to obtain A pregnen-3B,20{5'-diol-l-one-3,20-diacetate (XX) which is treated with a Grignard reagent, such as CH MgI or CH MgBr, in a suitable solvent and subsequently decomposed, with an acid or a solution of NH Cl, to yield 1-methyl-A -pregnen-1,3,43,20fi-triol (XXI). By selective oxidation in the 20-position of (XXI), dissolved in an appropriate solvent such as acetone, with an aqueous solution of a mixture of chromic and sulphuric acids and at a temperature between 15 and +20 0, there may be obtained 1-methyl-A -pregnen-l,3fl-diol-20-one (XXII) which is further oxidised in the 3-position under the same conditions to give 1-methyl-A -pregnen-1-01-3,20- dione (XXIII), which may be prepared in a single step by oxidation of (XXI) under the above conditions. The product (XXIII) is rearranged to give l-methyl-l-hydroxyprogesterone (XXIV).
On hydrogenation of the l-monoacetatc of l-methyl- A -pregnadiene-1,3,8-diol-20-one (VI) in the presence of a catalyst such as palladium on charcoal, there is obtained the corresponding pregnene (XXV) which, dissolved in a suitable solvent such as acetone, is oxidised between l5 and +20 C. by an aqueous solution of a mixture of sulphuric acid and chromic acid to give 1- methyl-l-acetoxy-3,ZO-dioxo-pregn-S-ene (XXVI).
Treatment in acid medium of (XXVI) produces the migration of the double bond from the 5-position to the 4- position to give l-methyl-l-acetoxy-progesterone (XXVII).
, Treatment in alkaline medium of (XXVI) produces the migration of the double bond from the 5-position to the 4-position and the elimination of the acetoxy group in the l-position with formation of the double bond in 9 the 1-position to give l-methyl-1,2-dehydro-progesterone (XXVIII), which can also be prepared from (XXIII) or (XXIV) or (XXVII).
l-methyl-l-hydroxy-diosgenin (Va) and l-methyl-lhydroxy-A -dehydrodiosgenin (Vb) can be selectively acetylated in the 3-position to give the corresponding acetates (XXIXa and XXIXb respectively). Dehydration, for example by means of thionyl chloride, of the acetates gives essentially the 3-acetate of l-methylene-diosgenin (XXXa) and the 3 -acetate of l-rnethylene-A -dehydrodisgenin (XXXb) which, on catalytic hydrogenation, such as with palladium on charcoal, give the corresponding l-methyl derivatives (XXXIa and XXXIc). By degradation of these latter compounds, there is obtained l-rnethyl-3fl-hydroxy-A pregnadien-ZO-one (XXXII), of which the double bond in the 16-p0sition is selectively hydrogenated in the presence of a suitable catalyst such as palladium on charcoal. There is thus obtained 1-methyl-3fi-hydroxy-M- pregnen-ZO-one (XXXIII), which, dissolved in an appropriate solvent such as acetone, is oxidised at a temperature between and C. with an aqueous solution of a mixture of chromic and sulphuric acids, to give 1 methyl A pregnen 3,20-dione (XXXIV). 1- methyl-progesterone (XXXV) is prepared from (XXXIV) by causing migration of the double bond from the 5-position to the 4-position by means of an acid or alkaline medium.
Saponification of (XXXa) and (XXXb) gives the corresponding 3-hydroxy derivatives (XXXVTa, XXXVIb) which, on hydrogenation in the presence of a catalyst such as palladium, gives l-methyl-diosgenin (XXXVIIa) and l-methyl-yamogenin (XXXVIIc), respectively.
The preparation of 1-methyl-l7a-acetoxy-progesterone (XLVII) from the 3-acetate of 1-methylene-A dehydrodiosgenin (XXXb) may be effected as follows. Degradation of (XXXb) gives l-methylene-ZB-acetoxy- A5116 -pregnadien-20-one (XXXVIII) which is dissolved in a suitable solvent such as methanol and epoxidised in the 16, 17-position, by treatment with hydrogen peroxide under strongly alkaline conditions, to give 1-methylene-3B- acetoxy-16a,17ot-epoxy A pregnen-ZO-one (XXXIX). Acetylation of (XXXIX) forms the corresponding 318- acetoxy compound (XL) and treatment of the latter in solution in peroxide-free dioxan with an iodine-free solution of hydriodic acid under oxygen-free conditions causes rupture of the epoxy ring giving l-methylene-B/iacetoxy 16/3 iodo 170: hydroxy A pregnen 20 one (XLI). Reduction of (XLI) with Raney nickel and ethanol eliminates the 16, 3-iodine atom to give 1- methylene 3B acetoxy 17a hydroxy A pregnen ZO-one (XLII) and acetylation of this compound gives the corresponding 17a-acetoxy compound (XLIII). Hydrogenation of (XLIII) in the presence of Adams platinum saturates the '1 -methylene group to give 1- methyl 35,17a diacetoxy A pregnen 2O one (XLIV) and by selective saponification of the latter in the 3-position with HCl and methanol there is obtained 1 methyl 3B hydroxy 17a acetoxy A pregnen ZO-one (XLV). Oxidation of (XLV) with a solution prepared as described in procedure A(ii) which follows gives 1 methyl 17a acetoxy A pregnen 3,20-dione (XLVI) and heating this in acid medium eifects transposition of the A double bond tto the 4-position thus giving l-methyl-17a-acetoxy-progesterone (XLVII).
The examples set forth below will serve to illustrate the production of compounds according to the invention. The temperatures are given in degrees centigrade. The following procedures are illustrative of the production of intermediate compounds:
(A) l-KETO-DIOSGENIN (Ha) FROM RUSCOGENIN (Ia) (i) 40 grams of ruscogenin dissolved in 4 00 ml. of
10 pyridine are added to a suspension of CrO -pyridine complex in pyridine (prepared from 40 g. of CrO and 400 ml. of pyridine) with stirring and at room temperature. After 20 hours of stirring the mixture is poured into 3.2 l. of water. The product is extracted with benzene, the organic extracts are washed with water, dried and evaporated to dryness under vacuum. The residue is crystallised from ethyl acetate. Yield: 12.75 g. of l-keto-diosgenin (Ila) melting at 220-222.
(ii) 14 millilitres of an oxidising solution (prepared from 266 g. of CrO 230 ml. of cone. H 400 ml. of water and the resulting solution diluted with water to 1 litre) are added to a solution of 20 g. of ruscogenin in 2400 ml. of acetone with stirring at 15. After 1.5 minutes, 20 ml. of a 30% aqueous solution of NaHSO are added and after 10 minutes stirring a solution of sodium acetate (13 g. of sodium acetate 31-1 0 and 30 ml. of water) is introduced. The mixture is concentrated to 400 ml. under vacuum and slowly poured into 2 l. of Water. The prepiciptate is filtered, washed with water, dried and crystallised from acetone. Yield: 10.16 g. of (11a) melting at 21'8224.
(B) RUSCOGENIN-3-ACETATE (IIIa) FROM RUSCOGENIN (Ia) A mixture of 140 g. of ruscogenin, 33610 ml. of acetic acid and 560 g. of acetic anhydride is heated for 18 hours at 60. The solution is evaporated to dryness in vacuo. The crystalline residue is washed with 1 litre. of ether, in which the 3-acetate of ruscogenin is scarcely soluble. ing of the insoluble matter, there are obtained 49 g. of the first fraction, melting point 2-28231.
The residue obtained by evaporation of the washing ether of the first fraction is agitated for 1 hour with 460 ml. of boiling di-isopropyl ether. The suspension is filtered while hot and the insoluble matter is washed with ml. of di-isopropyl ether.
After drying, there are recovered 17.5 g. of the second fraction, instantaneous melting point 229-231.
Saponification with alcoholic potassium hydroxide of the residue of evaporation of the diisopropyl ether which has been employed to purify the second fraction permits of recovering 67 g. of ruscogenin, melting point 198- 202.
(C) NEORUSCOGENIN-3-ACETATE (1111;) FROM NEORUSCOGENIN (Ib) By proceeding as in the case of ruscogenin, g. of neoruscogenin give:
Neoruscogenin-3-acetate, first fraction: 57 g., melting point 240-245 Neoruscogenin-3-acetate, second fraction, recrystallised from isopropanol: 11.4 g., melting point 2 40-245.
Saponification by means of alcoholic potassium hydroxide of the residue of evaporation of the mother liquors of the second fraction permits of recovering 75 g. of neoruscogenin, melting point 19220 0 (D) l-KETO-DIOSGENIN-3-ACETATE (IVa) FROM (Ha) (E) 1-KETO-DIOSGENIN-3-ACETATE (IVa) FROM (Illa) 34 g. of ruscogenin-3-acetate dissolved in 4590 ml. of acetone are treated with 20.4 ml. of the oxidising solution prepared in procedure A(ii) at 13-15 with agitation in a nitrogen atmosphere. The solution is agitated After filtration, washing with ether and dry- 11 for 4 minutes, whereafter 4590 ml. of water are added thereto. After agitation for 1 hour at the precipitate is filtered, washed with 50% acetone and dried. There are obtained 32.2 g. of 1-keto-diosgenin-3-acetate melting at 192194.
(F) l-KETO-A -DEHYDRODIOSGENlN-3 ACETATE (lVb) F ROM (11111) 25 g. of neoruscogenin-3-acetate dissolved in 3375 ml. of acetone are treated with 15 ml. of the oxidising solution prepared in procedure A(ii) at 15 with agitation in a nitrogen atmosphere. The solution is agitated for 4 minutes, whereafter 3375 ml. of water are added thereto. After agitation for a quarter of an hour, the precipitate is filtered, washed with 50% acetone and dried. There are obtained 22.3 g. of 1-keto-A'- -dehyclrodiosgenin-3- acetate, M.P. 228-232.
Example 1 1-METHYL1-HYDROXY-DIOSGENIN (Va) FROM. (Ila) 16.96 grams of l-keto-diosgenin dissolved in 400 ml. of anhydrous benzene are added to a solution of methylmagnesium iodide in ether (prepared from 40 g. of Mg, 130 g. of CH I and 760 ml. of anhydrous ether). The suspension is warmed at 4547 for 7 days and then slowly poured into an aqueous solution of NH Cl in Water (360 g. of NH Cl in 1900 ml. of iced water). The organic layer is separated and the aqueous solution is extracted with ether again. The combined organic extracts are washed with Water, dried and evaporated to dryness. The residue is dissolved in 150 ml. of benzene and chromatographed on 400 g. of Florisil. l-methyl-l-hydroxydiosgenin is eluted with a benzene-ether mixture (1:1). 13.4 grams of (Va) melting at 200 are obtained.
Example 2 1-l\1ETHYL-1-HYDROXY-DIOSGENIN (Va) FROM (IVa) 7 To a solution of CH MgI (prepared from 2.9 g. of Mg and 17 g. of CH I) in 255 ml. of anhydrous ether is slowly added with gentle boiling a solution of 9.5 g. of (IVa) in 500 ml. of tetrahydrofuran. This addition takes about 1 hour. Ether is distilled otf and, during the distillation, tetrahydrofuran is added until the internal temperature rises to 63. At this point the distillation is interrupted and the mixture is boiled for 15 hours. The suspension is treated with 400 m1. of a 25% aqueous solution of NH CI and, by operating in the usual manner, 5.1 g. of crude l-methyl-l-hydroxy-diosgenin melting at 195-205 is obtained. After crystallisation from aqueous methanol there is obtained 4.35 g. of pure l-methyl-l-hydroxydiosgenin (Va) melting at 215-216".
Example 3 l-ME'IHYL-l-HYDROXY-A -DEHYDRODIOSGENIN (Vb) FROM (IVE) Y To a solution of methylmagnesium iodide (prepared from 3.86 g. of magnesium and 24.85 g. of methyl iodide in 266 ml. of anhydrous ether) there is added slowly a solution of 10 g. of 1-keto-A -dehydrodiosgenin-3-acetate (IVb) in 350 ml. of anhydrous benzene. The mixture is refluxed for 3 hours, shaken for a further hours at room temperature and then treated with 500 ml. of a aqueous solution of ammonium chloride.
After the usual treatment, the crude product dissolved in benzene is chromatographed on 95 g. of Woelm neutral alumina (activityzl). A small ketone fraction is eluted by 380 ml. of benzene and then the column is eluted by 950 ml. of ethanol. The alcoholic eluate is evaporated to dryness under vacuum and the residue is recrystallised from a 10% solution of methanol in di-isopropyl ether. There is obtained 3.55 g. of l-methyl-lhydroxy-A (27)-dehydrodiosgenin (Vb), melting at 168- 176. The pure product, obtained by crystallisation from ethyl acetate, melts at 192194.
l-METHYL-lJlYDROXY-A -DEHYDRODIOSGENIN-3- ACETATE (XXIXD) FROM (Vb) A solution of 4 g. of (Vb) in 36 ml. of pyridine and 25 ml. of acetic anhydride is heated for 1 hour on a Water bath. After cooling, the solution is poured into 300 ml. of iced water. The precipitate is filtered, washed with water and dried. After recrystallisation from ethanol, 2.85 g. of (XXIXb) are obtained, M.P. 222226.
Example 6 1-METHYLENE-DIOSGENIN-3-ACETATE (XXXa) FROM (XXIXa) 6 millilitres of thionyl chloride are poured drop-bydrop into a solution of 10 g. of (XXIXa) in 170 ml. of pyridine maintained at 0. The solution is then agitated for 15 minutes at 0 and then poured into 900 ml. of iced water. The precipitate is filtered, washed with Water, dried and recrystallised from ethanol and then from isopropanol. 4.37 g. of (XXXa) are obtained, M.P. 156.
Example 7 l-METHYL-DIOSGENIN-3-ACETATE (XXXIa) FROM (XXXa) 2 grams of l-methylene-diosgenin-3-acetate (XXXa) are hydrogenated in 225 ml. of ethanol in the presence of 1.5 g. of 5% palladium on charcoal at room temperature and atmospheric pressure. After fixation of 1 mole equivalent of hydrogen, the hydrogenation is stopped. The catalyst is filtered and the alcoholic liquor distilled to dryness in vacuo.
After repeated recrystallisations of the residue from ethanol, 0.4 g. of (XXXIa) are obtained, M.P. 146148, [M (c.=1, CHCl Example 8 l-METHYLENE-A -DEHYDRODIO S GEN IN-S-ACETATE (XXXb) FROM (XXIXb) 6.9 millilitres of thionyl chloride are poured drop-bydrop into a solution of 11.5 g. of (XXIXb) in 195 ml. of pyridine maintained at 0. The solution is thereafter agitated for 15 minutes at 0 and then poured into 1 litre of ice water. The precipitate is filtered, washed with water, dried and recrystallised from ethanol. 9.6 grams of (XXXb) are obtained, M.P. 155. The pure product obtained by repeated crystallisations from ethanol melts at l87.
Example 9 l-METI-IYL-YAMOGENIN-3-ACETATE (XXXIc) FRO M (XXXb) 5.7 grams of 1-methylene-A -dehydrodiosgenin-3- acetate (XXXb) are hydrogenated in 635 cc. of ethanol in the presence of 5 .7 g. of 5% palladium on charcoal under atmospheric pressure and at ambient temperature. After fixation of 2 mole equivalents of hydrogen, the hydrogenation is stopped. The catalyst is filtered and the alcoholic liquor is evaporated to dryness in vacuo.
After crystallisation of the residue from isopropanol, 2.81 g. of (XXXIc) are obtained, M.P.=18l183, [a] (c.:l, CHCl )=90.
Example LMETHYLENE-DIO SGENIN (XXXVIIL) FROM (XXXII) 8.17 grams of 1 methylene diosgenin 3 acetate (XXXa), prepared as described in Example 6 are added to a solution of 8.17 g. of potassium hydroxide pellets in 817 cc. of methanol; the mixture is heated to reflux for one hour under nitrogen and with agitation. After cooling the solution 8.17 cc. of acetic acid are added thereto and the mixture is evaporated to dryness under vacuum; the crystalline residue is taken up in 250 cc. of water, the solution filtered and the residue Washed with water and then dried over night under vacuum in the presence of concentrated sulphuric acid.
The crude produce is dissolved in 134 cc. of benzene and then chromatographed on a column of silica gel (134 g.). Elution of the column with a benzene ethyl acetate mixture (95:5) leads to the isolation of 5.09 g. of l-methylene-diosgenin, M.P. 148 149, [06113 =91i5 (c.=1, chloro-form).
Example 11 l-METHYLENE-M -DEHYDRODIOSGENIN (XXXVIb) FROM (XXXb) Following the procedure described in Example 10, but starting with 13.3 g. of 1-rnethylene-A -dehydrodiosgenin-3-acetate (XXXb) (M.P. 145-155) prepared as described in Example 8, there is obtained 5.73 g. of lmethylene-A -dehydrodiosgenin, M.P. l7l173.
Example 12 l-METHYL-DIOSGENIN (XXXVIIa) FROM (XXXVIa) 1.33 grams of l-methylene-diosgenin (XXXVIa) dissolved in 66 cc. of ethanol are hydrogenated in the presence of 2.66 g. of 3% palladium on charcoal under atmospheric pressure and at room temperature. The hydrogenation is stopped after the absorption of 1.4 mole equivalents of hydrogen; the catalyst is then filtered off and the ethanolic solution evaporated to dryness under vacuum.
The crude product is dissolved in 50* cc. of benzene and then chromatographed on a column of silica gel (25 g.). Elution of the column with a benzene-ethyl acetate mixture (9:1) gives 0.63 g. of l-methyl-diosgenin, MP. 125- 130.
Example 13 l-lVLER'llI-IYLYAMO'GENIN (XXXVIIc) FROM (XXXVIb) 2 grams of 1 methylene A dehydrodiosgenin (XXXVIb) dissolved in 100 cc. of ethyl acetate are hydrogenated in the presence of 1.6 g. of 10% palladium on barium sulphate under atmospheric pressure and at room temperature. The hydrogenation is stopped after the absorption of 2.3 mole equivalents of hydrogen; the catalyst is then filtered off and the filtrate evaporated to dryness under vacuum.
The crude product is purified by two crystallisations from ethanol and there is obtained 0.32 got l-methylyamogenin, M.P. 177178.
Example 14 l-METHYL-DIOSGENIN ACETATE (XXXIa) FROM '(XXXa) 6.9 grams of l-methylene-diosgenin acetate (XXXa) are hydrogenated in a mixture of 414 cc. ethyl acetate and 13.8 cc. acetic acid in the presence of 0.69 g. of Adams platinum at ordinary pressure and temperature; the ab sorption of hydrogen is very rapid and when it falls to about 2 cc. of hydrogen per minute the hydrogenation is stopped, the volume of hydrogen absorbed then corre- 14 sponding to about 1.1 molecular equivalents. The duration of the hydrogenation is 45 minutes.
The catalyst is filtered off and the filtrate evaporated to dryness under vacuum. After recrystallisation of the residue from 63 cc. of ethanol there is obtained 4.49 g. of (XXXIa), melting point 147149, [a] -=92:2 (c. =1, chloroform).
This application is a continuation-in-part of application Serial No. 64,462, filed October 24, 1960, now abandoned.
We claim:
1. l-methylene-diosgenin.
2. 1-methylene-diosgenin-3-acetate.
3. l-methylene-A -dehydrodiosgenin.
4. 1-methylene-A -dehydrodiosgenin-3-acetate.
5. A process for the preparation of a compound selected from the class consisting of l-methyl-l-hydroxydiosgenin and l-methyl-l-hydroxy A dehydrodiosgenin which comprises oxidising in the 1-position a compound selected from the class consisting of ruscogenin and neoruscogenin with a reagent selected from the class consisting of a sulphuric acid-chromic acid mixture and a pyridine-chromic anhydride complex, reacting the l-keto derivative thus obtained with a methyl magnesium halide and hydrolysing the resultant magnesium complex.
6. A process for the preparation of a compound selected from the class consisting of l-methyl-l-hydroxydiosgenin and l-methyl-l-hydroxy A dehydrodiosgenin which comprises acetylating in the 3-position a compound selected from the class consisting of ruscogenin and neoruscogenin with acetic anhydride, oxidising the acetyl derivative obtained with an agent selected from the class consisting of a sulphuric acid-chromic acid mixture and a pyridine-chromic anhydride complex, whereby the l-hydroxy group is converted to a l-oxo group, reacting the keto derivative obtained with a methyl magnesium halide and hydrolysing the resultant magnesium complex.
7. A process for the preparation of a compound selected from the class consisting of l-methylene-diosgenin and 1-methy1ene-A -dehydrodiosgenin which comprises acetylating in the 3-position a compound selected from the class consisting of 1-methyl-l-hydroxy-diosgenin and l-methyl-l-hydroxy A dehydrodiosgenin with acetic anhydride, reacting the acetyl derivative thus obtained with thionyl chloride and de-acetylating the resultant product by reacting it with an alkali metal hydroxide.
8. A process for the preparation of a compound selected from the class consisting of l-methyl-diosgenin and l-methyl-yamogenin which comprises hydrogenating a compound selected from the class consisting of l-methylene-diosgenin and l-methylene-A -dehydrodiosgenin with hydrogen in the presence of palladium.
9. A process for the preparation of a compound selected from the class consisting of l-methyl-diosgenin-3- acetate and l-methyl-yamogenin-S-acetate which comprises hydrogenating a compound selected from the class consisting of 1-methylene-diosgenin-3-acetate and 1-metl1- ylene A2597) dehydrodiosgenin 3 acetate in an ethyl acetate-acetic acid medium and in the presence of a reagent selected from the class consisting of palladium and Adams platinum.
10. l-methyl 1 hydroxy A dehydrodiosgenin which has melting point 192194 C.
11. l-methyl 1 hydroxy A dehydrodiosgenin 3-acetate which has melting point 222-226" C.
References Cited in the file of this patent Fieser et al.: Steroids (1959), Reinhold Publishing Company, pages 549 and 831 relied on.
Claims (1)
1. 1-METHYLENE-DIOSGENIN. 10. 1-METHYL - 1 - HYDROXY - $25(27) - DEHYDRODIOSGENIN WHICH HAS MELTING POINT 192-194*C.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB36664/59A GB963482A (en) | 1959-10-28 | 1959-10-28 | New steroids and new processes for the preparation of steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3134769A true US3134769A (en) | 1964-05-26 |
Family
ID=10390154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US130358A Expired - Lifetime US3134769A (en) | 1959-10-28 | 1961-08-09 | 1-methyl-diosgenins |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US3134769A (en) |
| GB (1) | GB963482A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3501504A (en) * | 1968-02-23 | 1970-03-17 | Searle & Co | 1-methylen-5alpha-androstan-17-one and derivatives thereof |
-
1959
- 1959-10-28 GB GB36664/59A patent/GB963482A/en not_active Expired
-
1961
- 1961-08-09 US US130358A patent/US3134769A/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| None * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3501504A (en) * | 1968-02-23 | 1970-03-17 | Searle & Co | 1-methylen-5alpha-androstan-17-one and derivatives thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| GB963482A (en) | 1964-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5933600B2 (en) | Method for producing novel 11,11-alkylidene steroids | |
| US3166577A (en) | 1, 2-dimethyl estrogens and intermediates used in the production thereof | |
| Ringold et al. | Steroids. LXXXV. 1 Synthesis of 4-Methyl and 4, 4-Dimethyl Hormone Analogs2 | |
| Sondheimer et al. | Steroids. LXVII. 1 The Decarboxylation of Unsaturated Steroidal Acids. Synthesis of 17-Epitestosterone and of 17-Methylepitestosterone2 | |
| US3262949A (en) | 7-methyl androstane compounds | |
| US3200113A (en) | 7-cyano steroids and derivatives thereof | |
| Djerassi et al. | Steroidal Sapogenins. XVI. 1a Introduction of the 11-Keto and 11α-Hydroxy Groups into Ring C Unsubstituted Steroids (Part 3). 1b 11-Oxygenated Sapogenins | |
| US3309387A (en) | 19-lower alkyl androstanes and pregnanes | |
| Djerassi et al. | The Constitution and Stereochemistry of Digitogenin1 | |
| US2768189A (en) | Method of producing alpha-brominated keto steroid compounds | |
| US3134769A (en) | 1-methyl-diosgenins | |
| US3849402A (en) | 19-oxygenated and 19-nor delta8(14)-steroid compounds | |
| US3637770A (en) | Process for the production of 16alpha 17alpha-dihydroxy-19-nor-progesterone | |
| US3515719A (en) | 7-methyl-6,19-epoxy steroids of the androstane series | |
| US3254098A (en) | Process for the production of 19 norandrostanes and 19 nor-pregnanes | |
| Romo et al. | Steroids. XLI. 1 Synthesis of 11α, 17α-Dihydroxyprogesterone and of 11α, 17α, 21-Trihydroxyprogesterone, the 11-Epimer of Kendall's Compound F2 | |
| US3271390A (en) | Sulfurenic acid and derivatives thereof | |
| US2773888A (en) | Process for the manufacture of 3-ketals of polyketo steroids and products obtained thereby | |
| US3134793A (en) | 1-methyl-pregnanes | |
| US3083199A (en) | delta3-5alpha-steroids and 3alpha-hydroxy-5alpha-steroids and the preparation thereof | |
| US2963493A (en) | Androstan-16-ol-3-one compounds and the production thereof | |
| US3781271A (en) | Process for the production of 14beta-hydroxy-delta16-and 7alpha-hydroxy-delta4-steroids | |
| US3270007A (en) | Process for cyclopentanophenanthrene compounds | |
| US3574196A (en) | Steroidal 1,4-dienes | |
| US3080381A (en) | Optionally 6-methylated and optionally 17-alkanoyloxygenated 2-oxapregnane-3, 20-diones, a-homo compounds corresponding, and 4, 5-dehydro and 4, 5; 6, 7-bisdehydro derivatives thereof |